| 1 | marrow | 2,407 |
| 2 | turnover | 1,777 |
| 3 | resorption | 1,204 |
| 4 | marrow-derived | 243 |
| 5 | densitometry | 204 |
| 6 | microarchitecture | 83 |
| 7 | setters | 39 |
| 8 | mineralisation | 27 |
| 9 | lyses | 14 |
| 10 | resorbing | 12 |
| 11 | resorptions | 12 |
| 12 | setter | 8 |
| 13 | micro-architecture | 7 |
| 14 | microdamage | 7 |
| 15 | turn-over | 7 |
| 16 | spavin | 6 |
| 17 | formation-stimulating | 5 |
| 18 | scintimetry | 5 |
| 19 | micro-structure | 4 |
| 20 | post-autologous | 4 |
| 21 | transparencies | 4 |
| 22 | 25-35-induced | 3 |
| 23 | chlorantha | 3 |
| 24 | marrow- | 3 |
| 25 | marrow/stem | 3 |
| 26 | enzyme-positive | 2 |
| 27 | iv-positive | 2 |
| 28 | marrow-supported | 2 |
| 29 | marrow/peripheral | 2 |
| 30 | resortion | 2 |
| 31 | strength/geometry | 2 |
| 32 | tumor-autologous | 2 |
| 33 | 1+/cd34+ | 1 |
| 34 | 47-positive | 1 |
| 35 | absorption/synthesis | 1 |
| 36 | adenovirus-tranduced | 1 |
| 37 | anabolism/resorption | 1 |
| 38 | breakability | 1 |
| 39 | concen- | 1 |
| 40 | cytokine-signalling | 1 |
| 41 | edema/osteitis | 1 |
| 42 | formation-initially | 1 |
| 43 | graftfigure | 1 |
| 44 | graftingclinical | 1 |
| 45 | hexaloba | 1 |
| 46 | i-positive | 1 |
| 47 | ingrowths | 1 |
| 48 | levels.sk-br-3 | 1 |
| 49 | loss-rates | 1 |
| 50 | loss/turnover | 1 |
| 51 | marrow-confirmed | 1 |
| 52 | marrow-mononuclear | 1 |
| 53 | marrow-soaked | 1 |
| 54 | marrow/cns | 1 |
| 55 | matrix-producing | 1 |
| 56 | matrixfigure | 1 |
| 57 | metastases/lesions | 1 |
| 58 | mineral/peptide-15 | 1 |
| 59 | neoplasms/ | 1 |
| 60 | oligomer-treated | 1 |
| 61 | onsurrogate | 1 |
| 62 | pain/myalgia | 1 |
| 63 | post-allogenic | 1 |
| 64 | productstreated | 1 |
| 65 | re-contouring | 1 |
| 66 | resorption-inhibitory | 1 |
| 67 | resportion | 1 |
| 68 | restore® | 1 |
| 69 | s100+ | 1 |
| 70 | spotorno | 1 |
| 71 | synthesis/absorption-related | 1 |
| 72 | turnover-serum | 1 |
| 73 | turnover.our | 1 |
| 74 | ≤12.0x106 | 1 |
| 1 | 1+/cd34+ | 1 |
| 2 | 25-35-induced | 3 |
| 3 | 47-positive | 1 |
| 4 | absorption/synthesis | 1 |
| 5 | adenovirus-tranduced | 1 |
| 6 | anabolism/resorption | 1 |
| 7 | breakability | 1 |
| 8 | chlorantha | 3 |
| 9 | concen- | 1 |
| 10 | cytokine-signalling | 1 |
| 11 | densitometry | 204 |
| 12 | edema/osteitis | 1 |
| 13 | enzyme-positive | 2 |
| 14 | formation-initially | 1 |
| 15 | formation-stimulating | 5 |
| 16 | graftfigure | 1 |
| 17 | graftingclinical | 1 |
| 18 | hexaloba | 1 |
| 19 | i-positive | 1 |
| 20 | ingrowths | 1 |
| 21 | iv-positive | 2 |
| 22 | levels.sk-br-3 | 1 |
| 23 | loss-rates | 1 |
| 24 | loss/turnover | 1 |
| 25 | lyses | 14 |
| 26 | marrow | 2,407 |
| 27 | marrow- | 3 |
| 28 | marrow-confirmed | 1 |
| 29 | marrow-derived | 243 |
| 30 | marrow-mononuclear | 1 |
| 31 | marrow-soaked | 1 |
| 32 | marrow-supported | 2 |
| 33 | marrow/cns | 1 |
| 34 | marrow/peripheral | 2 |
| 35 | marrow/stem | 3 |
| 36 | matrix-producing | 1 |
| 37 | matrixfigure | 1 |
| 38 | metastases/lesions | 1 |
| 39 | micro-architecture | 7 |
| 40 | micro-structure | 4 |
| 41 | microarchitecture | 83 |
| 42 | microdamage | 7 |
| 43 | mineral/peptide-15 | 1 |
| 44 | mineralisation | 27 |
| 45 | neoplasms/ | 1 |
| 46 | oligomer-treated | 1 |
| 47 | onsurrogate | 1 |
| 48 | pain/myalgia | 1 |
| 49 | post-allogenic | 1 |
| 50 | post-autologous | 4 |
| 51 | productstreated | 1 |
| 52 | re-contouring | 1 |
| 53 | resorbing | 12 |
| 54 | resorption | 1,204 |
| 55 | resorption-inhibitory | 1 |
| 56 | resorptions | 12 |
| 57 | resortion | 2 |
| 58 | resportion | 1 |
| 59 | restore® | 1 |
| 60 | s100+ | 1 |
| 61 | scintimetry | 5 |
| 62 | setter | 8 |
| 63 | setters | 39 |
| 64 | spavin | 6 |
| 65 | spotorno | 1 |
| 66 | strength/geometry | 2 |
| 67 | synthesis/absorption-related | 1 |
| 68 | transparencies | 4 |
| 69 | tumor-autologous | 2 |
| 70 | turn-over | 7 |
| 71 | turnover | 1,777 |
| 72 | turnover-serum | 1 |
| 73 | turnover.our | 1 |
| 74 | ≤12.0x106 | 1 |
| 1 | s100+ | 1 |
| 2 | 1+/cd34+ | 1 |
| 3 | concen- | 1 |
| 4 | marrow- | 3 |
| 5 | neoplasms/ | 1 |
| 6 | levels.sk-br-3 | 1 |
| 7 | mineral/peptide-15 | 1 |
| 8 | ≤12.0x106 | 1 |
| 9 | hexaloba | 1 |
| 10 | chlorantha | 3 |
| 11 | pain/myalgia | 1 |
| 12 | post-allogenic | 1 |
| 13 | adenovirus-tranduced | 1 |
| 14 | 25-35-induced | 3 |
| 15 | marrow-soaked | 1 |
| 16 | marrow-confirmed | 1 |
| 17 | oligomer-treated | 1 |
| 18 | productstreated | 1 |
| 19 | synthesis/absorption-related | 1 |
| 20 | marrow-supported | 2 |
| 21 | marrow-derived | 243 |
| 22 | microdamage | 7 |
| 23 | graftfigure | 1 |
| 24 | matrixfigure | 1 |
| 25 | micro-architecture | 7 |
| 26 | microarchitecture | 83 |
| 27 | micro-structure | 4 |
| 28 | onsurrogate | 1 |
| 29 | 47-positive | 1 |
| 30 | enzyme-positive | 2 |
| 31 | i-positive | 1 |
| 32 | iv-positive | 2 |
| 33 | resorbing | 12 |
| 34 | matrix-producing | 1 |
| 35 | cytokine-signalling | 1 |
| 36 | re-contouring | 1 |
| 37 | formation-stimulating | 5 |
| 38 | graftingclinical | 1 |
| 39 | marrow/peripheral | 2 |
| 40 | marrow/stem | 3 |
| 41 | turnover-serum | 1 |
| 42 | spavin | 6 |
| 43 | mineralisation | 27 |
| 44 | resorption | 1,204 |
| 45 | anabolism/resorption | 1 |
| 46 | resportion | 1 |
| 47 | resortion | 2 |
| 48 | spotorno | 1 |
| 49 | marrow-mononuclear | 1 |
| 50 | setter | 8 |
| 51 | turn-over | 7 |
| 52 | turnover | 1,777 |
| 53 | loss/turnover | 1 |
| 54 | turnover.our | 1 |
| 55 | transparencies | 4 |
| 56 | lyses | 14 |
| 57 | loss-rates | 1 |
| 58 | ingrowths | 1 |
| 59 | absorption/synthesis | 1 |
| 60 | edema/osteitis | 1 |
| 61 | marrow/cns | 1 |
| 62 | metastases/lesions | 1 |
| 63 | resorptions | 12 |
| 64 | setters | 39 |
| 65 | tumor-autologous | 2 |
| 66 | post-autologous | 4 |
| 67 | marrow | 2,407 |
| 68 | formation-initially | 1 |
| 69 | resorption-inhibitory | 1 |
| 70 | scintimetry | 5 |
| 71 | strength/geometry | 2 |
| 72 | densitometry | 204 |
| 73 | breakability | 1 |
| 74 | restore® | 1 |